Novartis AG

Switzerland


Create a watch for Novartis AG
Total IP 10,725
Total IP incl. subs 19,454 (+ 8,864 for subs)
Total IP Rank # 84
IP Activity Score 4.2/5.0    4,332
IP Activity Rank # 135
IP AS incl. subs 4.3/5.0    7,821
Stock Symbol
ISIN CH0012005267
Market Cap. 178.7B  (CHF)
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

1,910 1,172
592 826
3,354 2,004
867
 
Last Patent 2025 - Pharmaceutical products and stab...
First Patent 1977 - Organic compounds
Last Trademark 2025 - AUTHENTIFIELD
First Trademark 1942 - METHERGINE

Subsidiaries

119 subsidiaries with IP (5986 patents, 2878 trademarks)

89 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Pharmaceutical, medical and veterinary preparations, sanitary preparations for medical purposes, ...
G/S Downloadable software in the nature of a mobile application for providing information related to ...
G/S Non-medicated toilet preparations and skin care products; cosmetic and beauty preparations; cosme...
G/S Préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à sa...
G/S Downloadable podcasts in the field of breast cancer diagnosis, treatment and management Entertain...
G/S Pharmaceutical preparations.
G/S Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal prep...
G/S Providing a website featuring information in the field of the diagnosis and treatment of breast c...
G/S Downloadable software for healthcare professionals for the provision of information about radiol...
G/S Pharmaceutical preparations and gene therapy products in the nature of injectable biologic prepa...
Invention Regimens and methods of treating multiple sclerosis using ofatumumab. The disclosure is directed...
G/S Providing medical information to patients who are taking prescription medication for a cardiovasc...
Invention Piperidinyl-methyl-purineamines as nsd2 inhibitors and anti-cancer agents. The present invention...
G/S Creating an on-line community for patients, family members and caregivers in the field of spinal ...
Invention Crystalline form of lnp023. Described herein is a crystalline hydrate form of LNP023 hydrochlori...
Invention Pharmaceutical products and stable liquid compositions of il-17 antibodies. The disclosure is di...
Invention Method for measuring flow features in an inhaler, inhaler and system. The present invention rela...
Invention Trem2 stabilizing antibodies. The present invention provides antibodies that bind to and stabili...
Invention Methods of treating psoriatic arthritis using il-17 antagonists. The disclosure relates to novel...
Invention Factor b inhibitors for treatment of anca-associated vasculitis. Described herein are methods of ...
Invention 3-(1-oxo-5-(piperidin-4-yl)isoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof. Th...
Invention Solid support. A solid support for use in non-aqueous DNA-conjugated molecule reactions, wherein...
Invention Methods for improving the efficacy and expansion of immune cells. The invention provides methods...
Invention Improved production of angptl3 mimetics. The present invention pertains to the use of gene editin...
Invention Methods for treating cancer. Provided herein are methods for the treatment of cancers including p...
Invention Cyanotriazole compounds and uses thereof. The present invention provides a compound of Formula (I...
Invention Method for determining the purity of a compound by high-performance liquid chromatography. An ana...
Invention Remibrutinib drug substance and drug product substantially free of nitrosamine impurity. This inv...
Invention Remibrutinib drug substance and drug product substantially free of nitrosamine impurity. This in...
2024 Invention Compounds which bind to pnpla3i148m and their use to treat liver diseases. The invention relates ...
Invention Protein kinase c inhibitors for treatment of uveal melanoma. The present disclosure relates to u...
Invention Combination therapies comprising antibody molecules to tim-3. Combination therapies comprising a...
Invention Injection device and injection solution transferring system. An Injection device (10) comprises ...
Invention New crystalline forms of salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[...
Invention Cd19 binding molecules and uses thereof. The present disclosure provides CD19 binding molecules ...
Invention Pyrazolopyridine derivatives and uses thereof. The present disclosure relates to compounds of fo...
Invention Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory molecules....
Invention Car-expressing cells against multiple tumor antigens and uses thereof. The invention provides co...
Invention Nlrp3 inflammasome inhibitors. The present invention relates to novel pyridazin-3-yl phenol comp...
Invention Dosage regimen for a s1p receptor agonist. S1P receptor modulators or agonists are administered ...
Invention Novel rapamycin derivatives. The disclosure relates to compounds of formula (I) The disclosure...
Invention Octreotide depot formulation with constantly high exposure levels. The present invention relates...
Invention Naphthyridinone derivatives for the treatment of a disease or disorder. The invention relates to...
Invention Chimeric antigen receptor therapy in combination with il-15r and il15. The invention provides co...
Invention Anti-cd40 antibodies for use in treatment of sjogren's syndrome. The disclosure relates to metho...
Invention Methods of treatment with anti-factor xi/xia antibodies. The present invention relates to method...
Invention Rapcabtagene autoleucel for use in treating systemic lupus erythematosus. The invention provides ...
2023 Invention Medical autoinjector device
Invention Crystalline forms of an il-17 inhibitor. This application relates to crystalline forms of a smal...
Invention Complement factor b inhibitors and uses thereof. Provided herein are compounds of formula (I) an...
Invention Methods of treating disorders using anti-natriuretic peptide receptor 1 (npr1) antibodies. Descr...
Invention An oxaziridine platform for targeting functional allosteric methionine sites. The present disclo...
Invention Pyrazine amide derivatives. The present invention relates to pyrazine amide derivative compounds...
2022 Invention Branched triple lipid-modified nucleic acid compounds. Disclosed herein are compounds including ...
Invention Methods for improving adeno-associated virus (aav) delivery. Provided herein are methods for imp...
Invention Benzisoxazole derivatives and uses thereof. The present disclosure relates to compounds of formu...
Invention Pharmaceutical composition. The present invention relates to the field of pharmacy, particularly...
2021 Invention Expression technology for antibody constructs. The present invention pertains to expression vect...
Invention Anti-cd19 agent and b cell targeting agent combination therapy for treating b cell malignancies. ...
2020 Invention Crystalline forms of a btk inhibitor. This application relates to various anhydrous crystalline ...